Policosanol is a mixture of long-chain waxy alcohols extracted primarily from sugarcane wax. It’s sold as a dietary supplement, mostly marketed for lowering cholesterol, though its effectiveness is a matter of genuine scientific debate. The supplement has been studied since the 1990s, largely by Cuban researchers, and the results from those early trials painted a promising picture. Independent studies from other countries have been far less convincing.
What Policosanol Is Made Of
Policosanol isn’t a single compound. It’s a blend of several high-molecular-weight alcohols (not the drinking kind) that naturally coat the surfaces of plants as part of their protective waxy layer. The primary source is sugarcane wax, specifically from the species Saccharum officinarum. The dominant alcohol in the mix is octacosanol, a 28-carbon molecule that typically makes up more than half of the supplement by weight.
These same waxy alcohols show up in other plants too. Wheat bran and wheat germ contain notable amounts, with octacosanol again being a major component alongside shorter-chain relatives. Beeswax, rice bran, and yams also contain policosanol-type alcohols, though sugarcane remains the standard commercial source. Supplements derived from different plant sources can vary in their exact composition, which matters when comparing study results.
How It’s Supposed to Work
The proposed mechanism centers on cholesterol production in the liver. Your body manufactures most of its own cholesterol using an enzyme that acts as the master switch for the process. Statin drugs work by directly blocking this enzyme. Policosanol appears to take a different, less direct route.
Lab studies on cell cultures show that policosanol reduces cholesterol synthesis, but not by physically blocking the enzyme the way statins do. Instead, it seems to suppress the production of the enzyme itself or speed up its breakdown. The net effect, in theory, is that your liver makes less cholesterol. However, researchers have noted that the exact mechanism still isn’t fully understood, even after decades of study. This uncertainty is one reason the supplement remains controversial.
What the Cuban Studies Claimed
More than 50 studies, most conducted in Cuba, reported substantial reductions in blood lipid levels from policosanol. A clinical pharmacology review of this body of research summarized the findings: at doses of 10 to 20 mg per day, policosanol lowered total cholesterol by 17% to 21%, reduced LDL (“bad”) cholesterol by 21% to 29%, and raised HDL (“good”) cholesterol by 8% to 15%. Some Cuban head-to-head trials even compared it favorably against prescription cholesterol medications.
One such trial, in patients with high cholesterol and type 2 diabetes, found that 10 mg of policosanol daily lowered LDL cholesterol by 25.7% and total cholesterol by 18.2% over eight weeks. In the same study, a low-dose statin was more powerful for LDL reduction (41.9%), but policosanol actually outperformed it for raising HDL cholesterol (11.1% increase versus no significant change with the statin). The two treatments performed similarly for triglycerides and the overall cholesterol ratio.
Why Independent Studies Tell a Different Story
Here’s where things get complicated. Several animal and human trials conducted outside of Cuba, using both Cuban-sourced and non-Cuban policosanol, have failed to reproduce these results. A notable study testing authentic Cuban sugarcane policosanol in people with high cholesterol found no significant difference between the supplement and placebo for total cholesterol, LDL, HDL, or triglycerides.
This discrepancy has never been fully explained. Some researchers point to differences in study design, patient populations, or the specific composition of the supplements tested. Others are more blunt, questioning the clinical usefulness of policosanol as a cholesterol-lowering agent altogether. The gap between the Cuban data and independent replication attempts is one of the more unusual controversies in supplement research, and it remains unresolved.
Effects Beyond Cholesterol
Policosanol also has antiplatelet properties, meaning it can reduce the tendency of blood cells to clump together and form clots. A randomized, double-blind study found that when 10 mg of policosanol was combined with omega-3 fatty acids, platelet clumping triggered by various stimuli dropped by 20% to 43%, significantly more than omega-3s alone. Importantly, this did not increase bleeding time, suggesting the antiplatelet effect stayed within a safe range in that study.
Research on Cuban prehypertensive patients has also explored blood pressure effects, with some evidence that 20 mg daily may offer modest benefits. These secondary effects are less studied than the cholesterol claims and carry the same replication concerns.
Safety and Interactions
Policosanol is generally well tolerated in studies lasting over three years at doses up to 20 mg per day. Reported side effects tend to be mild. The more serious concern is its potential to act as a blood thinner.
Because of its antiplatelet activity, policosanol should not be combined with blood-thinning medications like warfarin, heparin, aspirin, or clopidogrel without medical guidance. The same caution applies to natural supplements with blood-thinning properties, including garlic, ginkgo, and high-dose vitamin E. People with clotting disorders or those approaching surgery should avoid it.
There’s also a reported interaction with levodopa, a Parkinson’s disease medication. At least one non-Cuban study suggested policosanol could amplify levodopa’s effects and side effects, particularly involuntary movements. Blood pressure medications and diabetes drugs may also interact poorly with policosanol.
Regulatory Status in the U.S.
Policosanol is not approved by the FDA as a drug. It’s sold as a dietary supplement, which means it doesn’t undergo the rigorous testing required for prescription medications. The FDA has taken enforcement action against supplement companies that market policosanol with explicit health claims. In a 2022 warning letter, the agency told one manufacturer that its policosanol product, marketed as managing lipid accumulation and lowering cholesterol, met the legal definition of an unapproved new drug. Supplements can legally be sold, but they cannot claim to treat, cure, or prevent disease.
Typical Dosage in Research
Clinical studies have most commonly used 5 to 20 mg of policosanol per day, with 10 mg being the standard dose in the majority of trials. Most supplements on the market fall within this range. The supplement is typically taken once daily with an evening meal, since cholesterol production in the liver peaks overnight. Higher doses up to 40 mg have been tested in some Cuban research, but 20 mg per day is the upper end of what’s been evaluated for long-term safety.